Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

Steven de Maat, Wariya Sanrattana, Reiner K. Mailer, Naomi M. J. Parr, Martin Hessing, Robert M. Koetsier, Joost C. M. Meijers, Gerard Pasterkamp, Thomas Renné, Coen Maas

Blood (2019) 134 (19): 1658–1669.

https://doi.org/10.1182/blood.2019000481

Published: 2019

Includes: Supplemental data

Journal Articles

Interrogation of the Coagulation Cascade Acute Coronary Syndrome Using Novel Elisa-Based Assays for Single Protease Quantification

Jens Posma, MSc, Rene van Oerle, Diane Fens, Jose govers Riemslag, PhD, Julia Mueller, PhD, Stefan Heitmeier, PhD, Hugo ten Cate, MD PhD, Henri M.H. Spronk, PhD

Blood (2018) 132 (Supplement 1): 5013.

https://doi.org/10.1182/blood-2018-99-118353

Published: 2018

Journal Articles

Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin

Ivan Tarandovskiy, PhD, Paul Buehler, Ph. D., Elena Karnaukhova

Blood (2017) 130 (Supplement 1): 2353.

https://doi.org/10.1182/blood.V130.Suppl_1.2353.2353

Published: 2017

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Jasmin Desai, MD, Catherine Broome, MD

Blood (2016) 128 (22): 4817.

https://doi.org/10.1182/blood.V128.22.4817.4817

Published: 2016

Journal Articles

TNT009 Prevents Erythrocyte C3 Fragment Opsonization and Rescues Reticulocytes from Destruction in Patients with Cold Agglutinin Disease

Sandip Panicker, PhD, Christa Drucker, Sami Hussain, Graham C Parry, PhD, James C Gilbert, MD, Bernd Jilma, MD, Ulrich Jaeger, MD

Blood (2016) 128 (22): 94.

https://doi.org/10.1182/blood.V128.22.94.94

Published: 2016

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

Erin Elizabeth Roesch, MD, Catherine Broome, MD

Blood (2015) 126 (23): 2253.

https://doi.org/10.1182/blood.V126.23.2253.2253

Published: 2015

Journal Articles

Waldenstrom's Microglobulinemia Presenting with Recurrent Angioedema Secondary to C1q Esterase Inhibitor (C1 INH) Deficiency

Nneamaka N Enwemnwa, MD, Abhinav B. Chandra, MD, MSc, Porselvi Chockalingam, MD, Jack Burton, MD

Blood (2010) 116 (21): 5009.

https://doi.org/10.1182/blood.V116.21.5009.5009

Published: 2010

Journal Articles

Parvovirus B19 Is Inactivated by Pasteurization, a Dedicated Virus Inactivation Step in the Manufacturing Process of Plasma-Derived Products.

Albrecht Groener, Thomas Nowak, Wolfram Schäfer

Blood (2009) 114 (22): 3152.

https://doi.org/10.1182/blood.V114.22.3152.3152

Published: 2009

Journal Articles

Two Virus Reduction Steps Are Inherent in the Manufacturing Process of Berinert P, a C1-Esterase-Inhibitor Concentrate.

Albrecht Groener, Thomas Nowak, Wolfram Schäfer

Blood (2005) 106 (11): 4170.

https://doi.org/10.1182/blood.V106.11.4170.4170

Published: 2005

Journal Articles

C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability

Dongxu Liu, Dong Zhang, Jennifer Scafidi, Xiao Wu, Cort C. Cramer, Alvin E. Davis, III

Blood (2005) 105 (6): 2350–2355.

https://doi.org/10.1182/blood-2004-05-1963

Published: 2005

Journal Articles

Pharmacokinetics of C1 Esterase Inhibitor, Human (Pasteurized) in Subjects with Hereditary Angioedema.

Wolfhart Kreuz, MD, Inmarculada Martinez-Saguer, MD, Hildegard Stoll, MD, Sigurd Knaub, PhD, Thomas Klingebiel, MD

Blood (2004) 104 (11): 1031.

https://doi.org/10.1182/blood.V104.11.1031.1031

Published: 2004

Journal Articles

Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - a Prospective Study.

Wolfhart Kreuz, MD, Inmarculada Martinez-Saguer, MD, Emel Aygoeren-Puersuen, MD, Eva Rusicke, MD, Thomas Klingebiel, MD

Blood (2004) 104 (11): 1028.

https://doi.org/10.1182/blood.V104.11.1028.1028

Published: 2004

NARROW

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

Interrogation of the Coagulation Cascade Acute Coronary Syndrome Using Novel Elisa-Based Assays for Single Protease Quantification

Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

TNT009 Prevents Erythrocyte C3 Fragment Opsonization and Rescues Reticulocytes from Destruction in Patients with Cold Agglutinin Disease

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

Waldenstrom's Microglobulinemia Presenting with Recurrent Angioedema Secondary to C1q Esterase Inhibitor (C1 INH) Deficiency

Parvovirus B19 Is Inactivated by Pasteurization, a Dedicated Virus Inactivation Step in the Manufacturing Process of Plasma-Derived Products.

Two Virus Reduction Steps Are Inherent in the Manufacturing Process of Berinert P, a C1-Esterase-Inhibitor Concentrate.

C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability

Pharmacokinetics of C1 Esterase Inhibitor, Human (Pasteurized) in Subjects with Hereditary Angioedema.

Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - a Prospective Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only